5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma

Published:2016-03-12 Issue:1 Volume:8 Page:
ISSN:1868-7075
Container-title:Clinical Epigenetics
language:en
Short-container-title:Clin Epigenet

Author:

Barazeghi Elham,Gill Anthony J.,Sidhu Stan,Norlén Olov,Dina Roberto,Palazzo F. Fausto,Hellman Per,Stålberg Peter,Westin Gunnar

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Developmental Biology,Genetics,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13148-016-0197-2

Reference41 articles.

1. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16:724–31.

2. Favia G, Lumachi F, Polistina F, D’Amico DF. Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg. 1998;22:1225–30.

3. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109:1736–41.

4. Westin G, Björklund P, Åkerström G. Molecular genetics of parathyroid disease. World J Surg. 2009;33:2224–33.

5. Sharretts JM, Simonds WF. Clinical and molecular genetics of parathyroid neoplasms. Best Pract Res Clin Endocrinol Metab. 2012;24:491–02.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms;Endocrine Pathology;2024-01-29

2. The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm;2023-06-14

3. Diagnosis and management of parathyroid carcinoma: a state-of-the-art review;Endocrine-Related Cancer;2023-04-01

4. Overview of the 2022 WHO Classification of Parathyroid Tumors;Endocrine Pathology;2022-02-17

5. Parathyroid cancer: A systematic review of diagnostic biomarkers;The Surgeon;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3